Sentry Investment Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-893
Closed -$59K 150
2025
Q4
$59K Hold
893
0.04% 326
2025
Q3
$61K Sell
893
-4,264
-83% -$337K 0.04% 322
2025
Q2
$432K Buy
5,157
+1,815
+54% +$142K 0.24% 86
2025
Q1
$206K Sell
3,342
-998
-23% -$81.4K 0.14% 157
2024
Q4
$337K Buy
4,340
+2,466
+132% +$183K 0.16% 132
2024
Q3
$126K Sell
1,874
-3,328
-64% -$273K 0.05% 292
2024
Q2
$590K Sell
5,202
-1,066
-17% -$135K 0.26% 82
2024
Q1
$869K Hold
6,268
0.34% 65
2023
Q4
$778K Buy
6,268
+4,024
+179% +$411K 0.33% 62
2023
Q3
$209K Sell
2,244
-4,435
-66% -$500K 0.1% 207
2023
Q2
$858K Buy
6,679
+4,113
+160% +$497K 0.32% 68
2023
Q1
$298K Sell
2,566
-1,120
-30% -$125K 0.12% 189
2022
Q4
$417K Buy
3,686
+356
+11% +$39.1K 0.18% 138
2022
Q3
$268K Buy
3,330
+774
+30% +$65.6K 0.13% 170
2022
Q2
$190K Sell
2,556
-500
-16% -$45.6K 0.09% 236
2022
Q1
$391K Sell
3,056
-516
-14% -$56.4K 0.12% 173
2021
Q4
$479K Buy
3,572
+244
+7% +$35.1K 0.13% 176
2021
Q3
$455K Sell
3,328
-488
-13% -$61.5K 0.13% 168
2021
Q2
$407K Hold
3,816
0.1% 198
2021
Q1
$343K Sell
3,816
-18,212
-83% -$1.71M 0.09% 224
2020
Q4
$2.04M Sell
22,028
-1,184
-5% -$106K 0.1% 194
2020
Q3
$2.39M Hold
23,212
0.13% 160
2020
Q2
$2.35M Buy
+23,212
New +$2.08M 0.14% 163

Other funds holding DXCM

Sentry Investment Management's DXCM Position: Q1 2026 in Review

Sentry Investment Management sold out of DexCom (DXCM) in Q1 2026, closing a stake of 893 shares — an estimated $59K sold.

Sentry Investment Management first reported a position in DXCM in Q2 2020 and held it in 23 quarters. The position peaked at $2.39M in Q3 2020. 960 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Sentry Investment Management reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • Sentry Investment Management sold 893 DexCom shares in Q1 2026, an estimated $59K.
  • Sentry Investment Management first reported a position in DexCom in Q2 2020 and held it in 23 quarters.
  • Sentry Investment Management's DexCom position peaked at $2.39M in Q3 2020.
  • 960 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Sentry Investment Management's 13F filing for Q1 2026, filed 8 May 2026.